The Centers for Medicare and Medicaid Services are being urged to make changes that could improve savings for patients and health care payers, as well as expand patient access to biosimilars.
Clinical pathway development needs to better take into account the patient perspective of cancer care, according to Alan Balch, PhD, in a presentation at the Clinical Pathways Congress.
The National Quality Forum has partnered with PatientsLikeMe to evaluate a novel approach of using online patient-reported data to guide the development and refinement of patient-reported outcome performance measures.
Clinical pathway implementation and adaptation requires proper leadership and appreciation of the nuances of organizations and patient populations, according to Aymen Elfiky, MD.
Multiple areas have been identified where oncology value frameworks can be revised in order to increase their utility to payers.